Gene expression analysis showed that the expression of MAPK8, CTNNB1, NFKB1, EGFR, CXCL8, CCL2, BCL2, and NFE2L2 increased or decreased in the hippocampus of patients with AD. Here, NFE2L2 is linked to Alzheimer disease.